Breaks Categories: Stock Spotlights

FridayJul 20, 2018 10:19 am

CBDNewsBreaks – Marijuana Company of America Inc. (MCOA) Subsidiary Targets Cosmetics Sector with Botanical Moisturizer

Marijuana Company of America (OTC: MCOA), through its hempSMART™ brand, recently announced the rollout of its latest cannabidiol-derived cosmetic product for people seeking an all-natural botanical moisturizer. An article further discussing the product reads: “The hempSMART™ Face product marks Marijuana Company of America’s expansion of its hempSMART™ brand into the cosmetic products space, building on a portfolio of legal CBD-based wellness innovations.  The company states that each bottle of its hempSMART™ Face (http://cnw.fm/nS7Qd) contains 150 mg of full-spectrum, non-psychoactive cannabidiol (CBD) oil derived from the industrial hemp plant. The new topical nourishes facial skin with ayurvedic herbs and botanicals that…

Continue Reading

MondayJul 16, 2018 3:01 pm

CBDNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Delivers Groundbreaking, Organic Options to Preventive Healthcare Market

PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) aims to be a leader in the preventive health sciences and provide revolutionary options for preventive and curative therapies utilizing organic products. An article discussing the company reads: “PreveCeutical currently has five research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity. The World Health Organization (WHO) states that some 425 million people around the world are living with diabetes, and that number is projected to rise to 629 million by 2045. Treating diabetes is a costly matter, both economically and in terms of physical…

Continue Reading

FridayJul 13, 2018 11:46 am

CBDNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Maintains Robust Suite of Products, Strong IP Portfolio

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is engaged in the development and commercialization of quality cannabinoid-based nutraceuticals and pharmaceuticals by utilizing unique drug delivery platform technologies. An article discussing the company reads: “Pivot Pharmaceuticals has a suite of 30 products ready for commercialization. The company also has a strong intellectual property (“IP”) portfolio for the formulation and delivery of cannabinoids. Pivot’s proposed product line comprises capsules and tablets, bulk powder, stick packs and beverages. Its product line also consists of water soluble oral solutions, lotions, creams, gels and pet supplements. … Pivot Pharmaceuticals has acquired the global rights…

Continue Reading

FridayJul 13, 2018 11:40 am

CBDNewsBreaks – Marijuana Company of America Inc. (MCOA) Improves Patent Pending hempSMART Brain Product Formulation

Marijuana Company of America (OTC: MCOA) functions as an umbrella company supporting an assortment of portfolio businesses operating in the legal cannabis and hemp industry. In June, the company announced that its hempSMART™ brand relaunched its flagship patent pending product, hempSMART™ Brain. An article further discussing the product reads: “The improved formulation includes 300mg per bottle of full spectrum, non-psychoactive, water soluble CBD (10mg per serving), along with a botanical blend of all-natural plant-based ingredients. To learn more about the hempSMART™ Brain product, read the full press release (http://cnw.fm/2dKSp). The brand offers a line of CBD products and the opportunity…

Continue Reading

FridayJul 13, 2018 10:47 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential in Alternative Nicotine Delivery Method

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) believes that its patented technology, DehydraTECH™ has the potential to transform nicotine use by offering a delivery method that may be an effective alternative to the traditional inhalation. An article discussing the company reads: “Although inhalation is an effective delivery mechanism – much more so than non-enhanced edible ingestion – it is dangerous. The toxins released during combustion are harmful and can potentially kill the user. Edible ingestion eliminates the toxins caused by lighting up. While inhalation is fast, traditionally, ingestion has not been. However, the use of DehydraTECH™ speeds things up to make…

Continue Reading

ThursdayJul 12, 2018 12:40 pm

CBDNewsBreaks – Why GreenBox POS, LLC (GRBX) is “One to Watch”

Innovative hardware and software technology company GreenBox POS, LLC (OTCQB: GRBX) builds customized payment solutions, such as point of sale (“POS”) systems, in a variety of industries. An article discussing the company reads: “GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.” To…

Continue Reading

FridayJul 06, 2018 11:29 am

CBDNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Subsidiary Advances in Canadian Cannabis Market

Vertically integrated cannabis company Sunniva’s (CSE: SNN) (OTCQX: SNNVF) wholly-owned subsidiary, Sunniva Medical Inc. (“SMI”), received a Confirmation of Readiness (“COR”) notification from Health Canada recently. Attaining the COR is a key step toward SMI receiving a license to produce. A recent article discussing the company reads: “The COR received by Sunniva Medical Inc. (SMI) was issued under new rules instituted in May 2017 by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), which removed the necessity for a physical inspection of grow facilities prior to the issuance of a cultivation license. The new regime allows…

Continue Reading

FridayJul 06, 2018 10:22 am

CBDNewsBreaks – Medical Cannabis Payment Solutions (REFG) Ensures FinCEN Compliance via Green Platform

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) has developed Green, a Financial Crimes Enforcement Network (“FinCEN”) compliant payment processing platform for the cannabis industry. A recent article discussing the company reads: “Medical Cannabis Payment Solutions (OTC: REFG), a financial services company directed at the medical cannabis and banking industries, has been filling the gap for cannabis providers who lack bank support due to federal regulations by providing online banking solutions. First offered only to medical cannabis merchants, the company’s services are now available to the entire cannabis industry through its innovative Green platform. The Green platform allows…

Continue Reading

FridayJul 06, 2018 10:13 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Out-licenses Disruptive Delivery Technology to Strategically Build Cash Flow

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has been strategically out-licensing its disruptive delivery technology and focusing on R&D to improve its value and increase cash flow. An article further discussing the company reads: “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent CFN Media Group interview that his company has gained in value and cash flow, purposely keeping its cash burn rate down and evaluating technology applications for both cannabis and other sectors (http://cnw.fm/4MDyw). … Bunka explained that LXRP is respecting its shareholders in terms of lowered spending and increasing its valuation, purposely maintaining its…

Continue Reading

ThursdayJul 05, 2018 3:07 pm

CBDNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Conducts Extensive Research on Sol-gel CBD-based Delivery System

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is presently working on the advancement of its Sol-gel drug delivery research program. An article discussing the company reads: “Currently, the company’s research is focused on testing various cannabis strains for the purpose of formulating potent and effective Sol-gels. PreveCeutical Chief Research Officer Dr. Harendra Parekh is leading the program. … In addition, various spray devices have already been tested. According to PreveCeutical CEO and President Stephen Van Deventer, a focus on safety regulations and a tamper-proof delivery system will be of paramount importance. While the Sol-gel program…

Continue Reading